Skip to main content
Erschienen in: Neurotherapeutics 1/2018

01.01.2018 | Review

Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis

verfasst von: Paolo Riccio, Rocco Rossano

Erschienen in: Neurotherapeutics | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Central to the understanding of the relationships between diet, gut microbiota, and vitamins D and A in multiple sclerosis is low-grade inflammation, which is involved in all chronic inflammatory diseases and is influenced by each of the above effectors. We show that food components have either proinflammatory or anti-inflammatory effects and influence both the human metabolism (the “metabolome”) and the composition of gut microbiota. Hypercaloric, high-animal-fat Western diets favor anabolism and change gut microbiota composition towards dysbiosis. Subsequent intestinal inflammation leads to leakage of the gut barrier, disruption of the blood–brain barrier, and neuroinflammation. Conversely, a vegetarian diet, rich in fiber, is coherent with gut eubiosis and a healthy condition. Vitamin D levels, mainly insufficient in a persistent low-grade inflammatory status, can be restored to optimal values only by administration of high amounts of cholecalciferol. At its optimal values (>30 ng/ml), vitamin D requires vitamin A for the binding to the vitamin D receptor and exert its anti-inflammatory action. Both vitamins must be supplied to the subjects lacking vitamin D. We conclude that nutrients, including the nondigestible dietary fibers, have a leading role in tackling the low-grade inflammation associated with chronic inflammatory diseases. Their action is mediated by gut microbiota and any microbial change induced by diet modifies host–microbe interactions in a consequent way, to improve the disease or worsen it.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Yong HY, Yong VW. Stop inflammation and you stop neurodegeneration in MS – YES. Mult Scler 2017; 23:1320-1321.CrossRefPubMed Yong HY, Yong VW. Stop inflammation and you stop neurodegeneration in MS – YES. Mult Scler 2017; 23:1320-1321.CrossRefPubMed
3.
Zurück zum Zitat Amato MP, Derfuss T, Hemmer B, et al. 2016 ECTRIMS Focused Workshop Group. Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop. Mult Scler 2017; 6:1352458516686847. Amato MP, Derfuss T, Hemmer B, et al. 2016 ECTRIMS Focused Workshop Group. Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop. Mult Scler 2017; 6:1352458516686847.
4.
Zurück zum Zitat Munger KL, Fitzgerald KC, Freedman MS, et al. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology 2015;85:1694-1701.PubMedCentralCrossRefPubMed Munger KL, Fitzgerald KC, Freedman MS, et al. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology 2015;85:1694-1701.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 2016; 71:26-34.CrossRefPubMed Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 2016; 71:26-34.CrossRefPubMed
6.
Zurück zum Zitat Munger KL. Childhood obesity is a risk factor for multiple sclerosis. Mult Scler 2013;19:1800.CrossRefPubMed Munger KL. Childhood obesity is a risk factor for multiple sclerosis. Mult Scler 2013;19:1800.CrossRefPubMed
7.
Zurück zum Zitat Liu Z, Zhang TT, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta-analysis. Neuroepidemiology 2016; 47:103-108.CrossRefPubMed Liu Z, Zhang TT, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta-analysis. Neuroepidemiology 2016; 47:103-108.CrossRefPubMed
8.
Zurück zum Zitat Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71:306-314.PubMedCentralCrossRefPubMed Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71:306-314.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord 2017; 14:35-45.CrossRefPubMed Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord 2017; 14:35-45.CrossRefPubMed
10.
Zurück zum Zitat Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimm Dis 2011; 2010:249842. Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimm Dis 2011; 2010:249842.
11.
Zurück zum Zitat Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011; 19:228-237.CrossRefPubMed Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011; 19:228-237.CrossRefPubMed
12.
Zurück zum Zitat Riccio P, Rossano R. The role of nutrition in multiple sclerosis: a story yet to be written. Rev Esp Esclerosis Multiple 2013; 5:24-37. Riccio P, Rossano R. The role of nutrition in multiple sclerosis: a story yet to be written. Rev Esp Esclerosis Multiple 2013; 5:24-37.
14.
Zurück zum Zitat Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18:153-165.CrossRefPubMed Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18:153-165.CrossRefPubMed
15.
Zurück zum Zitat Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014; 58:136-146.CrossRefPubMed Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014; 58:136-146.CrossRefPubMed
16.
Zurück zum Zitat Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012; 18:1334-1336.CrossRefPubMed Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012; 18:1334-1336.CrossRefPubMed
17.
Zurück zum Zitat Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1-12.CrossRefPubMed Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1-12.CrossRefPubMed
19.
Zurück zum Zitat Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-axis as possibility to modulate inflammatory disease activity-implications for multiple sclerosis. Int J Mol Sci 2017; 18: E1526.CrossRefPubMed Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-axis as possibility to modulate inflammatory disease activity-implications for multiple sclerosis. Int J Mol Sci 2017; 18: E1526.CrossRefPubMed
20.
Zurück zum Zitat Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165:1332-1345.CrossRefPubMed Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165:1332-1345.CrossRefPubMed
21.
Zurück zum Zitat Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 13:1476-1483.CrossRef Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 13:1476-1483.CrossRef
22.
Zurück zum Zitat De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107:14691-14696.PubMedCentralCrossRefPubMed De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107:14691-14696.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Bäckhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12:611-622.CrossRefPubMed Bäckhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12:611-622.CrossRefPubMed
25.
Zurück zum Zitat David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-563.CrossRefPubMed David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-563.CrossRefPubMed
26.
Zurück zum Zitat Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.CrossRefPubMed Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.CrossRefPubMed
27.
28.
Zurück zum Zitat Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLOS ONE 2017; 12:e0176715.PubMedCentralCrossRefPubMed Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLOS ONE 2017; 12:e0176715.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017; 19:29-41.CrossRefPubMed Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017; 19:29-41.CrossRefPubMed
32.
Zurück zum Zitat Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front Microbiol 2016; 7:979.PubMedCentralCrossRefPubMed Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front Microbiol 2016; 7:979.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014; 40:833-842.CrossRefPubMed Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014; 40:833-842.CrossRefPubMed
34.
Zurück zum Zitat Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6:234-242.PubMedCentralCrossRefPubMed Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6:234-242.PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Quévrain E, Maubert MA, Michon C, et al. Identification of an anti-inflammatory protein from Faecali bacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65:415-425.CrossRefPubMed Quévrain E, Maubert MA, Michon C, et al. Identification of an anti-inflammatory protein from Faecali bacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65:415-425.CrossRefPubMed
37.
Zurück zum Zitat Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586-597.PubMedCentralCrossRefPubMed Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586-597.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Lutgendorff F, Akkermans LM, Söderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med 2008; 8:282-298.CrossRefPubMed Lutgendorff F, Akkermans LM, Söderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med 2008; 8:282-298.CrossRefPubMed
39.
Zurück zum Zitat Shen T, Chen X, Li Y, et al. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochim Biophys Acta 2017; 1863:1510-1518. Shen T, Chen X, Li Y, et al. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochim Biophys Acta 2017; 1863:1510-1518.
40.
Zurück zum Zitat Park JH, Jeong SY, Choi AJ, Kim SJ. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett 2015; 165:10-19.CrossRefPubMed Park JH, Jeong SY, Choi AJ, Kim SJ. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett 2015; 165:10-19.CrossRefPubMed
41.
Zurück zum Zitat Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012; 142:1100-1101.PubMedCentralCrossRefPubMed Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012; 142:1100-1101.PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Ochoa-Repáraz J, Kasper LH. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep. 2016; 5(1):51-64. Ochoa-Repáraz J, Kasper LH. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep. 2016; 5(1):51-64.
43.
Zurück zum Zitat Scheperjans F. Can microbiota research change our understanding of neurodegenerative diseases? Neurodegener Dis Manag 2016; 6:81-85.CrossRefPubMed Scheperjans F. Can microbiota research change our understanding of neurodegenerative diseases? Neurodegener Dis Manag 2016; 6:81-85.CrossRefPubMed
44.
Zurück zum Zitat Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538-541.CrossRefPubMed Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538-541.CrossRefPubMed
45.
Zurück zum Zitat Miyake S, Kim S, Suda W, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV Clusters. PLOS ONE 2015; 10:e0137429.PubMedCentralCrossRefPubMed Miyake S, Kim S, Suda W, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV Clusters. PLOS ONE 2015; 10:e0137429.PubMedCentralCrossRefPubMed
46.
Zurück zum Zitat Chen J, Chia N, Kalari KR, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6:28484.PubMedCentralCrossRefPubMed Chen J, Chia N, Kalari KR, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6:28484.PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017. Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017.
48.
Zurück zum Zitat Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30:350-358.CrossRefPubMed Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30:350-358.CrossRefPubMed
49.
Zurück zum Zitat Bu XL, Yao XQ, Jiao SS, et al. A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol 2015; 22:1519-1525.CrossRefPubMed Bu XL, Yao XQ, Jiao SS, et al. A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol 2015; 22:1519-1525.CrossRefPubMed
50.
Zurück zum Zitat Bu XL, Wang X, Xiang Y, et al. The association between infectious burden and Parkinson's disease: a case-control study. Parkinsonism Relat Disord 2015; 21:877-881.CrossRefPubMed Bu XL, Wang X, Xiang Y, et al. The association between infectious burden and Parkinson's disease: a case-control study. Parkinsonism Relat Disord 2015; 21:877-881.CrossRefPubMed
51.
Zurück zum Zitat Buscarinu MC, Cerasoli B, Annibali V, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 2017; 23:442-446.CrossRefPubMed Buscarinu MC, Cerasoli B, Annibali V, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 2017; 23:442-446.CrossRefPubMed
52.
Zurück zum Zitat Wekerle H. Brain autoimmunity and intestinal microbiota. 100 Trillion game changers. Trends Immunol 2017; 1379:1-15. Wekerle H. Brain autoimmunity and intestinal microbiota. 100 Trillion game changers. Trends Immunol 2017; 1379:1-15.
53.
Zurück zum Zitat Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci 1950; 220:421-430.CrossRefPubMed Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci 1950; 220:421-430.CrossRefPubMed
54.
Zurück zum Zitat Swank RL, Goodwin JW. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003; 19:161-165.CrossRefPubMed Swank RL, Goodwin JW. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003; 19:161-165.CrossRefPubMed
55.
Zurück zum Zitat Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.PubMed Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.PubMed
56.
Zurück zum Zitat Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol 2016; 785:24-35.CrossRefPubMed Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol 2016; 785:24-35.CrossRefPubMed
58.
Zurück zum Zitat Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenicTh17 Cells. Nature 2013; 496:518-522.PubMedCentralCrossRefPubMed Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenicTh17 Cells. Nature 2013; 496:518-522.PubMedCentralCrossRefPubMed
59.
Zurück zum Zitat Riccio P. The proteins of the milk fat globule membrane in the balance. Trends Food Sci Technol 2004; 15:458-461.CrossRef Riccio P. The proteins of the milk fat globule membrane in the balance. Trends Food Sci Technol 2004; 15:458-461.CrossRef
60.
Zurück zum Zitat Choi IY, Lee P, Adany P, et al. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Mult Scler 2017. Choi IY, Lee P, Adany P, et al. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Mult Scler 2017.
61.
Zurück zum Zitat Frischer JM, Stephan Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.PubMedCentralCrossRefPubMed Frischer JM, Stephan Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.PubMedCentralCrossRefPubMed
63.
Zurück zum Zitat Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47:147-155.CrossRefPubMed Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47:147-155.CrossRefPubMed
64.
Zurück zum Zitat Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28:291-299.CrossRefPubMed Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28:291-299.CrossRefPubMed
65.
Zurück zum Zitat Huang JK, Jarjour AA, Oumesmar BN, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011; 14:45-53.CrossRefPubMed Huang JK, Jarjour AA, Oumesmar BN, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011; 14:45-53.CrossRefPubMed
66.
Zurück zum Zitat Qing J. Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic Biol Med 2014; 72: 76-90.CrossRef Qing J. Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic Biol Med 2014; 72: 76-90.CrossRef
67.
Zurück zum Zitat Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and non immune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol 2004; 172:6418-6426.CrossRefPubMed Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and non immune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol 2004; 172:6418-6426.CrossRefPubMed
69.
Zurück zum Zitat Fenni S, Hammou H, Astier J, et al. Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders. Mol Nutr Food Res 2017; 61(9). Fenni S, Hammou H, Astier J, et al. Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders. Mol Nutr Food Res 2017; 61(9).
70.
73.
Zurück zum Zitat Riccio P, Giovannelli S, Bobba A, et al. Specificity of zinc binding to myelin basic protein. Neurochem Res 1995; 20:1107-1113.CrossRefPubMed Riccio P, Giovannelli S, Bobba A, et al. Specificity of zinc binding to myelin basic protein. Neurochem Res 1995; 20:1107-1113.CrossRefPubMed
74.
Zurück zum Zitat Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLOS ONE 2010; 5:e13058.PubMedCentralCrossRefPubMed Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLOS ONE 2010; 5:e13058.PubMedCentralCrossRefPubMed
75.
Zurück zum Zitat Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice. J Neuroinflammation 2013; 10:73.PubMedCentralCrossRefPubMed Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice. J Neuroinflammation 2013; 10:73.PubMedCentralCrossRefPubMed
76.
Zurück zum Zitat Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 2014; 4:108-122.PubMedCentralCrossRefPubMed Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 2014; 4:108-122.PubMedCentralCrossRefPubMed
77.
Zurück zum Zitat Visioli F, De La Lastra CA, Andres-Lacueva C, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 2011; 51:524-546.CrossRefPubMed Visioli F, De La Lastra CA, Andres-Lacueva C, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 2011; 51:524-546.CrossRefPubMed
78.
Zurück zum Zitat Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med 2014; 11:151-169.CrossRefPubMed Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med 2014; 11:151-169.CrossRefPubMed
79.
Zurück zum Zitat Vijayakumar TM, Kumar RM, Agrawal A, Dubey GP, Ilango K. Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 2015; 52:4537-4543.CrossRefPubMed Vijayakumar TM, Kumar RM, Agrawal A, Dubey GP, Ilango K. Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 2015; 52:4537-4543.CrossRefPubMed
80.
Zurück zum Zitat Liuzzi GM, Latronico T, Branà MT, et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochem Res 2011; 36:518-527.CrossRefPubMed Liuzzi GM, Latronico T, Branà MT, et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochem Res 2011; 36:518-527.CrossRefPubMed
81.
Zurück zum Zitat Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxid Med Cell Longev 2015; 2015:217258.PubMedCentralCrossRefPubMed Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxid Med Cell Longev 2015; 2015:217258.PubMedCentralCrossRefPubMed
82.
Zurück zum Zitat Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017.
83.
Zurück zum Zitat Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519:92-96.PubMedCentralCrossRefPubMed Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519:92-96.PubMedCentralCrossRefPubMed
84.
Zurück zum Zitat Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2017. Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2017.
85.
Zurück zum Zitat Welzl H, D’Adamo P, Lipp HP. Conditioned taste aversion as a learning and memory paradigm. Behav Brain Res 2001; 125:205-213.CrossRefPubMed Welzl H, D’Adamo P, Lipp HP. Conditioned taste aversion as a learning and memory paradigm. Behav Brain Res 2001; 125:205-213.CrossRefPubMed
86.
Zurück zum Zitat Weiland TJ, Hadgkiss EJ, Jelinek GA, et al. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 336:211-219.CrossRefPubMed Weiland TJ, Hadgkiss EJ, Jelinek GA, et al. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 336:211-219.CrossRefPubMed
87.
Zurück zum Zitat Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2016; 18:1352-1363.CrossRefPubMed Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2016; 18:1352-1363.CrossRefPubMed
88.
Zurück zum Zitat Hedström AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014; 71:300-305.CrossRefPubMed Hedström AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014; 71:300-305.CrossRefPubMed
89.
Zurück zum Zitat Samuelson DR, Shellito JE, Maffei VJ, et al. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLOS Pathog 2017; 13:e1006426.PubMedCentralCrossRefPubMed Samuelson DR, Shellito JE, Maffei VJ, et al. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLOS Pathog 2017; 13:e1006426.PubMedCentralCrossRefPubMed
90.
Zurück zum Zitat Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukocyte Biol 2008; 84:940-948.PubMedCentralCrossRefPubMed Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukocyte Biol 2008; 84:940-948.PubMedCentralCrossRefPubMed
91.
Zurück zum Zitat Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 2016; 15:2136-2146.PubMedCentralCrossRefPubMed Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 2016; 15:2136-2146.PubMedCentralCrossRefPubMed
92.
Zurück zum Zitat Clauw DJ. Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome. Lancet 2017; 390:335-336.CrossRefPubMed Clauw DJ. Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome. Lancet 2017; 390:335-336.CrossRefPubMed
93.
Zurück zum Zitat Gacias M, Casaccia P. Promoting return of function in multiple sclerosis: an integrated approach. Mult Scler Relat Disord 2013; 2(4). Gacias M, Casaccia P. Promoting return of function in multiple sclerosis: an integrated approach. Mult Scler Relat Disord 2013; 2(4).
94.
Zurück zum Zitat Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine 2017; 57:262-271.CrossRefPubMed Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine 2017; 57:262-271.CrossRefPubMed
95.
Zurück zum Zitat Lunde LK, Skare Ø, Aass HC, et al. Physical activity initiated by employer induces improvements in a novel set of biomarkers of inflammation: an 8-week follow-up study. Eur J Appl Physiol 2017; 117:521-532.PubMedCentralCrossRefPubMed Lunde LK, Skare Ø, Aass HC, et al. Physical activity initiated by employer induces improvements in a novel set of biomarkers of inflammation: an 8-week follow-up study. Eur J Appl Physiol 2017; 117:521-532.PubMedCentralCrossRefPubMed
96.
Zurück zum Zitat Petriz BA, Castro AP, Almeida JA, et al. Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics. 2014;15:511.PubMedCentralCrossRefPubMed Petriz BA, Castro AP, Almeida JA, et al. Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics. 2014;15:511.PubMedCentralCrossRefPubMed
97.
Zurück zum Zitat Monda V, Villano I, Messina A, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev 2017; 2017:3831972.PubMedCentralCrossRefPubMed Monda V, Villano I, Messina A, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev 2017; 2017:3831972.PubMedCentralCrossRefPubMed
98.
Zurück zum Zitat Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12:CD004192.PubMed Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12:CD004192.PubMed
99.
100.
101.
Zurück zum Zitat Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 2014; 20:347-355.PubMedCentralCrossRefPubMed Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 2014; 20:347-355.PubMedCentralCrossRefPubMed
102.
103.
Zurück zum Zitat McDougall J, Thomas LE, McDougall C, et al. Effects of 7 days on an ad libitum low-fat vegan diet: the McDougall Program cohort. Nutr J 2014; 13:99.PubMedCentralCrossRefPubMed McDougall J, Thomas LE, McDougall C, et al. Effects of 7 days on an ad libitum low-fat vegan diet: the McDougall Program cohort. Nutr J 2014; 13:99.PubMedCentralCrossRefPubMed
104.
Zurück zum Zitat El-Chammas K, Danner E. Gluten-free diet in nonceliac disease. Nutr Clin Pract 2011; 26:294-299.CrossRefPubMed El-Chammas K, Danner E. Gluten-free diet in nonceliac disease. Nutr Clin Pract 2011; 26:294-299.CrossRefPubMed
105.
Zurück zum Zitat Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood) 2016; 24:620-635.CrossRef Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood) 2016; 24:620-635.CrossRef
106.
Zurück zum Zitat Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18:242-252.CrossRefPubMed Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18:242-252.CrossRefPubMed
107.
Zurück zum Zitat Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. Semin Neurol 2016; 36:103-114.CrossRefPubMed Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. Semin Neurol 2016; 36:103-114.CrossRefPubMed
108.
Zurück zum Zitat Charalambidou E., Pantzaris M., Patrikios I. Multiple sclerosis in Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis 2016; 4:1-9. Charalambidou E., Pantzaris M., Patrikios I. Multiple sclerosis in Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis 2016; 4:1-9.
109.
Zurück zum Zitat Massacesi L, Abbamondi AL, Giorgi C, Sarlo F, Lolli F, Amaducci L. Suppression of experimental allergic encephalomyelitis by retinoic acid. J Neurol Sci 1987; 80:55-64.CrossRefPubMed Massacesi L, Abbamondi AL, Giorgi C, Sarlo F, Lolli F, Amaducci L. Suppression of experimental allergic encephalomyelitis by retinoic acid. J Neurol Sci 1987; 80:55-64.CrossRefPubMed
110.
Zurück zum Zitat Al-Daghri NM, Guerini FR, Al-Attas OS, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLOS ONE 2014; 9:e102141.PubMedCentralCrossRefPubMed Al-Daghri NM, Guerini FR, Al-Attas OS, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLOS ONE 2014; 9:e102141.PubMedCentralCrossRefPubMed
111.
Zurück zum Zitat Polidoro L, Properzi G, Marampon F, et al. Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013; 6:221-231.CrossRefPubMed Polidoro L, Properzi G, Marampon F, et al. Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013; 6:221-231.CrossRefPubMed
112.
Zurück zum Zitat Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12:57.PubMedCentralCrossRefPubMed Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12:57.PubMedCentralCrossRefPubMed
113.
Zurück zum Zitat Jin D, Wu S, Zhang YG, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 2015; 37:996-1009.CrossRefPubMed Jin D, Wu S, Zhang YG, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 2015; 37:996-1009.CrossRefPubMed
114.
Zurück zum Zitat Sun J. VDR/vitamin D receptor regulates autophagic activity through ATG16L1. Autophagy 2016; 12:1057-1058.CrossRefPubMed Sun J. VDR/vitamin D receptor regulates autophagic activity through ATG16L1. Autophagy 2016; 12:1057-1058.CrossRefPubMed
116.
Zurück zum Zitat Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013; 3:e002170.PubMedCentralCrossRefPubMed Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013; 3:e002170.PubMedCentralCrossRefPubMed
119.
Zurück zum Zitat Smith P, Willemsen D, Popkes ML, et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife 2017;6:e27014.PubMedCentralPubMed Smith P, Willemsen D, Popkes ML, et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife 2017;6:e27014.PubMedCentralPubMed
121.
Zurück zum Zitat Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. The evolution of the host microbiome as an ecosystem on a leash. Nature 2017; 548:43-51.CrossRefPubMed Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. The evolution of the host microbiome as an ecosystem on a leash. Nature 2017; 548:43-51.CrossRefPubMed
122.
Zurück zum Zitat Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 535:56-64.CrossRefPubMed Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 535:56-64.CrossRefPubMed
123.
124.
Zurück zum Zitat Ochoa-Repáraz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69:240-247.CrossRefPubMed Ochoa-Repáraz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69:240-247.CrossRefPubMed
125.
Zurück zum Zitat Fernández Ó, Álvarez-Cermeño JC, Arroyo-González R, et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Rev Neurol 2012; 54:677-691.PubMed Fernández Ó, Álvarez-Cermeño JC, Arroyo-González R, et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Rev Neurol 2012; 54:677-691.PubMed
126.
Zurück zum Zitat Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a review. Nutr Neurosci 2017; 1-14. Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a review. Nutr Neurosci 2017; 1-14.
127.
Zurück zum Zitat Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 2017; 17:28.CrossRefPubMed Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 2017; 17:28.CrossRefPubMed
128.
Zurück zum Zitat Bagur MJ, Murcia MA, Jiménez-Monreal AM, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr 2017; 8:463-472.CrossRefPubMed Bagur MJ, Murcia MA, Jiménez-Monreal AM, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr 2017; 8:463-472.CrossRefPubMed
129.
Zurück zum Zitat Wekerle H. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology (Oxford) 2016; 55:68-75.CrossRef Wekerle H. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology (Oxford) 2016; 55:68-75.CrossRef
130.
Zurück zum Zitat Cosorich I, Dalla-Costa G, Sorini C, et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.PubMedCentralCrossRefPubMed Cosorich I, Dalla-Costa G, Sorini C, et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.PubMedCentralCrossRefPubMed
131.
Zurück zum Zitat Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority—and the national multiple sclerosis society is responding. US Neurology 2015; 11:80-86.CrossRef Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority—and the national multiple sclerosis society is responding. US Neurology 2015; 11:80-86.CrossRef
132.
Zurück zum Zitat Motl RW, Mowry EM, Ehde DM, et al. Wellness and multiple sclerosis: the national MS society establishes a wellness research working group and research priorities. Mult Scler 2017. Motl RW, Mowry EM, Ehde DM, et al. Wellness and multiple sclerosis: the national MS society establishes a wellness research working group and research priorities. Mult Scler 2017.
Metadaten
Titel
Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis
verfasst von
Paolo Riccio
Rocco Rossano
Publikationsdatum
01.01.2018
Verlag
Springer US
Erschienen in
Neurotherapeutics / Ausgabe 1/2018
Print ISSN: 1933-7213
Elektronische ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-017-0581-4

Weitere Artikel der Ausgabe 1/2018

Neurotherapeutics 1/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.